SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

Erin M. Scherer; Ahmed Babiker; Max W. Adelman; Brent Allman; Autum Key; Jennifer M. Kleinhenz; Rose M. Langsjoen; Phuong Vi Nguyen; Ivy Onyechi; Jacob D. Sherman; Trevor W. Simon; Hannah Soloff; Jessica Tarabay; Jay Varkey; Andrew S. Webster; Daniela Weiskopf; Daniel B. Weissman; Yongxian Xu; Jesse J. Waggoner; Katia Koelle; Nadine Rouphael; Stephanie M. Pouch; Anne Piantadosi

doi:10.1056/NEJMc2202861

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia KoelleNadine Rouphael, Stephanie M. Pouch, Anne Piantadosi

Research output: Contribution to journal › Letter › peer-review

42 Scopus citations

Original language	English (US)
Pages (from-to)	2436-2438
Number of pages	3
Journal	New England Journal of Medicine
Volume	386
Issue number	25
DOIs	https://doi.org/10.1056/NEJMc2202861
State	Published - Jun 23 2022

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc2202861

Cite this

Scherer, E. M., Babiker, A., Adelman, M. W., Allman, B., Key, A., Kleinhenz, J. M., Langsjoen, R. M., Nguyen, P. V., Onyechi, I., Sherman, J. D., Simon, T. W., Soloff, H., Tarabay, J., Varkey, J., Webster, A. S., Weiskopf, D., Weissman, D. B., Xu, Y., Waggoner, J. J., ... Piantadosi, A. (2022). SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients. New England Journal of Medicine, 386(25), 2436-2438. https://doi.org/10.1056/NEJMc2202861

Scherer, EM, Babiker, A, Adelman, MW, Allman, B, Key, A, Kleinhenz, JM, Langsjoen, RM, Nguyen, PV, Onyechi, I, Sherman, JD, Simon, TW, Soloff, H, Tarabay, J, Varkey, J, Webster, AS, Weiskopf, D, Weissman, DB, Xu, Y, Waggoner, JJ, Koelle, K, Rouphael, N, Pouch, SM & Piantadosi, A 2022, 'SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients', New England Journal of Medicine, vol. 386, no. 25, pp. 2436-2438. https://doi.org/10.1056/NEJMc2202861

@article{03a3ef5f740b4c7bab217f084dd02bfb,

title = "SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients",

author = "Scherer, {Erin M.} and Ahmed Babiker and Adelman, {Max W.} and Brent Allman and Autum Key and Kleinhenz, {Jennifer M.} and Langsjoen, {Rose M.} and Nguyen, {Phuong Vi} and Ivy Onyechi and Sherman, {Jacob D.} and Simon, {Trevor W.} and Hannah Soloff and Jessica Tarabay and Jay Varkey and Webster, {Andrew S.} and Daniela Weiskopf and Weissman, {Daniel B.} and Yongxian Xu and Waggoner, {Jesse J.} and Katia Koelle and Nadine Rouphael and Pouch, {Stephanie M.} and Anne Piantadosi",

note = "Funding Information: Supported by a contract (75D30121C10084 under BAA ERR 20-15-2997, to Drs. Babiker, Waggoner, Koelle, and Piantadosi) from the Centers for Disease Control and Prevention ; by a grant (5UM1AI148576-02, to Drs. Rouphael and Scherer) from the National Institutes of Health ( NIH ); by a Simons Foundation Investigator Award in the Mathematical Modeling of Living Systems (to Dr. Weissman); and by the Pediatric Research Alliance Center for Childhood Infections and Vaccines (to Dr. Piantadosi) and Children{\textquoteright}s Healthcare of Atlanta and the Emory Woodruff Health Sciences Center Covid-19 Urgent Research Engagement (CURE) Center with support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation (to Drs. Piantadosi and Waggoner). Research reported in this letter was supported by a grant (K08AI139348, to Dr. Piantadosi) from the National Institute of Allergy and Infectious Diseases of the NIH and a contract (75N9301900065, to Dr. Weiskopf) from the NIH . La Jolla Institute for Immunology has filed for patent protection for various aspects of T-cell epitope and vaccine design work. ",

year = "2022",

month = jun,

day = "23",

doi = "10.1056/NEJMc2202861",

language = "English (US)",

volume = "386",

pages = "2436--2438",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "25",

}

TY - JOUR

T1 - SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

AU - Scherer, Erin M.

AU - Babiker, Ahmed

AU - Adelman, Max W.

AU - Allman, Brent

AU - Key, Autum

AU - Kleinhenz, Jennifer M.

AU - Langsjoen, Rose M.

AU - Nguyen, Phuong Vi

AU - Onyechi, Ivy

AU - Sherman, Jacob D.

AU - Simon, Trevor W.

AU - Soloff, Hannah

AU - Tarabay, Jessica

AU - Varkey, Jay

AU - Webster, Andrew S.

AU - Weiskopf, Daniela

AU - Weissman, Daniel B.

AU - Xu, Yongxian

AU - Waggoner, Jesse J.

AU - Koelle, Katia

AU - Rouphael, Nadine

AU - Pouch, Stephanie M.

AU - Piantadosi, Anne

N1 - Funding Information: Supported by a contract (75D30121C10084 under BAA ERR 20-15-2997, to Drs. Babiker, Waggoner, Koelle, and Piantadosi) from the Centers for Disease Control and Prevention ; by a grant (5UM1AI148576-02, to Drs. Rouphael and Scherer) from the National Institutes of Health ( NIH ); by a Simons Foundation Investigator Award in the Mathematical Modeling of Living Systems (to Dr. Weissman); and by the Pediatric Research Alliance Center for Childhood Infections and Vaccines (to Dr. Piantadosi) and Children’s Healthcare of Atlanta and the Emory Woodruff Health Sciences Center Covid-19 Urgent Research Engagement (CURE) Center with support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation (to Drs. Piantadosi and Waggoner). Research reported in this letter was supported by a grant (K08AI139348, to Dr. Piantadosi) from the National Institute of Allergy and Infectious Diseases of the NIH and a contract (75N9301900065, to Dr. Weiskopf) from the NIH . La Jolla Institute for Immunology has filed for patent protection for various aspects of T-cell epitope and vaccine design work.

PY - 2022/6/23

Y1 - 2022/6/23

UR - http://www.scopus.com/inward/record.url?scp=85133101335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133101335&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2202861

DO - 10.1056/NEJMc2202861

M3 - Letter

C2 - 35675197

AN - SCOPUS:85133101335

SN - 0028-4793

VL - 386

SP - 2436

EP - 2438

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 25

ER -

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this